Europe · Markets & Finance · Zonebourse

Cours Sagimet Biosciences Inc.

Published by Zonebourse · France 9 h ago

21:55 Sagimet Biosciences Inc. annonce les résultats positifs complets à 52 semaines de l’étude clinique d’extension en ouvert de phase 3 menée par son partenaire licencié…

Read the full article on Zonebourse Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.zonebourse.com)

Also worth reading

City A.M.

Bring ‘punishing’ high street taxes in line with banks, Healey urged

Financial Times

Trump says South Korea will invest $200bn in US energy projects

This is Money

Bailey's fears AI could trigger next crash should not be sneezed at, says ALEX BRUMMER

FXStreet

The New Zealand Dollar edges lower as US yields outweigh China's beats

Reuters Markets

Fed's Kashkari says central bank must lower inflation pressures

Reuters Sustainability